Magister Scientiae - MSc (Pharmacy Administration and Policy Regulation)

Permanent URI for this collection

https://hdl.handle.net/10566/14971

Browse

Browsing by Author "Bheekie, Angeni"

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Community pharmacists’ knowledge, attitude and practices on adverse drug reaction reporting in South Africa
    (University of the Western Cape, 2018) Mayne, Rensche; Bheekie, Angeni
    Pharmacovigilance involves the management of sub-standard drugs, medication errors, ―off-licence‖ drugs, abuse and misuse, lack of efficacy, poisoning, adverse drug reactions (ADRs), drug interactions, expired stock destruction and drug-related mortality. Regulators and the pharmaceutical industry rely on healthcare professionals, including pharmacists, to report ADRs. The majority of pharmacists work in retail community pharmacies and they are often the first point of contact when ADRs are experienced, since self-medication, misuse of over-the-counter (OTC) medicines, vitamins and traditional medicines, increase the probability of ADRs. In South Africa (SA) ADRs have been known to cause adult deaths and hospital admissions. In first-world communities, pharmacovigilance is more common among pharmacists, however in South Africa, ADR reporting compares poorly. Studies in the public sector have found that pharmacists lack pharmacovigilance knowledge and underreport ADRs. In comparison the pharmacovigilance knowledge and practice patterns among retail community pharmacists is poorly documented.
  • Thumbnail Image
    Item
    Exploring the factors influencing the sustainability of mobile clinics for the delivery of the expanded programme on immunisation to the rural areas of the Northern Cape.
    (University of Western Cape, 2021) Losper, Julia; Bheekie, Angeni
    The Northern Cape province has not been able to achieve the 90% immunization target recommended for South Africa’s expanded programme on immunisation (EPI). The situation has been attributed to the lack of access to EPI in the rural community. The Northern Cape’s poor infrastructure renders the provision of equitable preventive care service to rural communities a complex and costly task. The province is predominantly a rural setting consisting of farmland, with low population densities, and many residents have poor access to public transport to receive primary health care services from surrounding fixed or satellite clinics. Consequently, mothers often do not adhere to the immunization schedules, and lack awareness of the risks associated with the failure to have their infants vaccinated against communicable diseases. EPI services delivered via mobile clinics serve the primary health care needs for rural communities, but their sustainability remains a challenge. Additional barriers are found in literature which highlighted the shortage of health professionals, unreliable funding, limited transportation within rural areas and deficiencies in maintenance and suitability of mobile clinic vehicles.
  • Thumbnail Image
    Item
    An investigation into the competency framework required for the responsible pharmacist in the pharmaceutical manufacturing sector in South Africa
    (The University of the Western Cape, 2017) Dockrat, Leila; Bheekie, Angeni
    The pharmaceutical manufacturing sector operates within a highly regulated environment, with companies accountable to South African statutory bodies. The responsible pharmacist (RP) is responsible for their company’s adherence to the legislation requirements. Whilst the Pharmacy and the Medicines Acts outline the RP’s, there is no mandatory training requirement prior to registration as an RP, nor thereafter. This study investigated the role and competencies required of newly registered RPs in meeting their professional responsibilities in the pharmaceutical manufacturing sector. An online survey questionnaire elicited responses from RPs (n=102) about views and perceptions pertaining to their role and responsibilities. In addition, semi-structured interviews were conducted with statutory (n=3) and non-statutory representatives (n=5). Survey findings indicated that the majority (89,5%) of RPs felt competent and that they possessed the necessary skills and training. Almost two-thirds of respondents (63,2%) were experienced RPs who shared some reservations, that RPs may be excluded from far-reaching decisions with potential consequences for the company and patients. They added that RP performance monitoring was not regular, which may indicate that some companies view the RP as an appointment of convenience. The majority of respondents (89,5 %) were in favour of the development of training guidelines Findings from the semi-structured interviews indicated that RPs were not fully aware of their scope of duties and the implications thereof. The interviewees were also concerned that some companies, by not giving the RP role the level of importance and authority it required, were practicing tokenism. Further, that not all RPs had the necessary in-depth knowledge of the applicable laws, regulations, guidelines and codes. A competency framework for newly appointed RPs is needed to streamline their roles and responsibilities in the pharmaceutical manufacturing sector